What if we found cancer early enough to make a difference

The Galleri® multi-cancer early detection test detects more than 50 types of cancer.1,2 It’s now available to eligible Writer employees at no cost.

The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. Galleri should be used in addition to healthcare provider recommended screening tests.

Galleri Lifestyle Shot10 4043

The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. Galleri should be used in addition to healthcare provider recommended screening tests.

Key benefits of the Galleri test

hourglass icon

Early cancer detection

Detects many cancers not commonly screened for today, to allow for earlier treatment.1

stethoscope icon

Testing with ease

Completed with a simple blood draw.

blue test result icon

Actionable results

If a cancer signal is found, the results can point to where in the body the cancer is coming from with high accuracy.

The Galleri test is a screening test and does not detect all cancers.
Further testing is needed to diagnose cancer if a signal is detected.

Who is eligible?

Writer is excited to partner with GRAIL to provide access to the Galleri test as an annual benefit. The test is accessible at no cost to Writer employees that meet the following eligibility criteria established by Writer in partnership with GRAIL.

Eligibility requirements

  • 50 years or older
  • Not currently pregnant

OR

  • 22-49+ years old AND with certain risk factors
Black couple sitting at their kitchen table writing on a notepad with a cup of coffee and a tablet on the table in front of them

Our testing process

illustrated graphic of a Black male doctor in a white lab coat reading a chart

Request the test

Get started by creating a Galleri portal account and completing an online test request which includes questions about your medical history (about 10 minutes).
illustrated graphic of the Galleri test box sitting on a table in front of a window

Receive a collection kit

If the PWNHealth physician confirms you are eligible, you can schedule a blood draw at one of GRAIL’s blood draw partners and we will ship you a Galleri collection kit for your appointment.
illustrated graphic of a white, gray haired female patient having her blood drawn

Provide your sample

The trained technician that draws your blood sample will ship the kit back to the GRAIL lab.
Illustrated graphic of a black man sitting in a blue armchair and reviewing test results on a tablet

Receive your results

PWNHealth will reach out when your results are ready — about 2 weeks after your blood draw. Your test result will be shared with you by PWNHealth.

What is the Galleri test?

Galleri is a multi-cancer early detection (MCED) test that looks for a cancer signal across more than 50 types of cancer. It's a screening test, which means that while it does not diagnose cancer, it can improve your chance of finding it early.

illustrated video poster of the Galleri test sitting on a table in an examination room with an anatomy poster on the wall behind it

Frequently Asked Questions

The full cost of the Galleri test is covered. The cost of the blood draw is also included if you visit a GRAIL partner lab. If you choose to complete the blood draw at another lab, including your primary healthcare provider’s office, you will be responsible for the blood draw fee.

As part of this benefit offering, eligible Writer employees are each limited to one Galleri test over a 12 month period. In the event that a diagnostic evaluation after a ​“Cancer Signal Detected” result with Galleri does not confirm cancer, employees may be eligible for a complementary re-test with Galleri.

No, employees must request the test online through GRAIL’s patient portal where an independent healthcare provider from PWNHealth will review your request and order the test if appropriate.

When you request the test, you are given the option to enter your primary healthcare provider’s contact information so your test result is automatically shared if a cancer signal is detected. If no cancer signal is detected, you can share the result with your provider, but we will not automatically send it.

The Galleri test is currently available as a benefit offering to full-time Writer employees aged 50 years and older, or 22– 49 with certain risk factors. If you are not eligible for this benefit but would still like to learn more about the test, visit galleri.com.

All full-time Writer employees aged 50 years and older, as well as those 22 – 49 years old with certain risk factors, are eligible for the Galleri test at no cost to the eligible employee (eligible employee only, no dependents). Other family members not eligible through Writer’s benefit may learn more about the test on galleri.com. The family member would be responsible for the cost of the test and provider services.

The Galleri test is a multi-cancer early detection test that detects a cancer signal across more than 50 types of cancer, many of which are not commonly screened for today, through a simple blood draw. The Galleri test does not diagnose cancer and not all cancers may be detected in the blood.

The Galleri test is intended to be used in addition to, and not replace, other cancer screening tests your healthcare provider recommends.

The Galleri test looks for signals present in the blood that may be associated with cancer at the time of your blood draw. If a cancer signal is detected, the results can point to where in the body the cancer signal is coming from with high accuracy to help your healthcare provider guide next steps.

Family history is only one of many risk factors associated with cancer development. Other risk factors include eating habits, lifestyle, living or working environments, genetics, and many others.

When you submit your test request, you may ask for a pre-test consultation with a PWNHealth provider to discuss whether the test is right for you. This optional consultation is included in the benefit.

In a clinical validation study (CCGA3*), the Galleri test detected more than 50 types of cancer across all stages.

*Circulating Cell-Free Genome Atlas (CCGA) sub-study

The Galleri test detects more than 50 types of cancers, however not all cancers may be detected in the blood. Recommended routine cancer screening tests such as colonoscopy or mammograms have been shown to reduce cancer deaths. 

The Galleri test is intended to be used in addition to and not replace these tests, and can help maximize the benefits of early cancer detection. Missing recommended screening or ignoring symptoms could lead to a delayed diagnosis of cancer.

Based on data from our studies, the Galleri test has shown a low false-positive rate of 0.5% (detects a cancer signal when no cancer is present). This means that in approximately 200 people tested only 1 person would be expected to receive a false positive result.

The Galleri test development was supported by what is believed to be one of the largest clinical study programs in genomic medicine, with over 20,000 participants at more than 140 clinical study sites, including the Mayo Clinic, Dana-Farber Cancer Institute, Cleveland Clinic, Sutter Health, OHSU, Intermountain Healthcare, and U.S. Oncology Network.

The Galleri test has not been cleared or approved by the FDA. GRAIL’s clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists (CAP). GRAIL’s clinical laboratory is regulated under CLIA to perform high-complexity testing.

The Galleri test received FDA Breakthrough Device Designation in 2019.

To access the Galleri test as a covered benefit, you must request the test through galleri.com/partner/writer. An independent healthcare provider from PWNHealth will review your request and order the test if appropriate.

A healthcare provider from PWNHealth will review your request and clinical eligibility within one week. They will approve your request and order the test if appropriate.

If the PWNHealth provider approves your request, you will be shipped a Galleri specimen collection kit and receive an email confirmation with instructions for how to schedule your blood draw.

When your collection kit arrives, you can schedule a blood draw at one of GRAIL’s partner labs, which is covered in this benefit. PWNHealth will reach out when your results are ready — in about 2 weeks after completing your blood draw.

If your Galleri test request is approved and your collection kit has arrived, you can schedule a blood draw appointment with one of GRAIL’s partner labs at no cost to you. 

Please note that completing your blood draw at some place other than one of GRAIL’s partner labs will not be covered by this benefit.

Bring your unopened Galleri specimen collection kit and your completed and printed ​‘Test Requisition Form’ to your blood draw appointment. 

You will receive these items if your eligibility for the Galleri test is approved. 

  • collection kit will be mailed to you within one week after your request is approved. Do not break the quality seal on the collection kit. It should be opened by the lab technician who draws your blood sample. 

  • A completed Test Requisition Form will be emailed to you from GRAIL. Remember to print the form and bring it to your appointment. 

The Test Requisition Form is the ordering form the provider completes to order the test for you. You will receive this document via an order confirmation email from GRAIL if the provider orders your test.

No preparation or fasting is required. Some lab technicians may ask if you have fasted (no eating or drinking), but this is not required for the Galleri test.

Please do not break the quality seal on the collection kit. It must be opened by the lab technician who draws your blood sample. 

Store the collection kit at room temperature until your blood draw appointment. The contents are sensitive to extreme temperatures. For example, avoid storing your collection kit in the trunk of your car. Your next step is to schedule your blood draw at a GRAIL partner lab.

The collection kit includes instructions for the lab technician, two tubes for the blood sample, and packing materials to ensure the sample is safely shipped to GRAIL.

Please do not break the quality seal on the collection kit. It must be opened by the lab technician who draws your blood sample.

The trained practitioner who draws your blood will pack and ship your sample back to the GRAIL laboratory for processing.

Approximately 1.5 tablespoons (or about 20 mL) of blood in two tubes typically from a vein in your arm.

It takes about 2 weeks after your blood draw to receive your test results from the PWNHealth provider that ordered your test. PWNHealth will reach out when your results are ready.

If you no longer wish to receive your Galleri results, please contact PWNHealth to request a cancellation at gc@​pwnhealth.​com or 888−494−7333.

If you are unable to reach PWNHealth or require further assistance, please contact GRAIL Customer Service at customerservice@​grail.​com or 833−694−2553.

This means that no cancer signal was found. However, not all cancers can be detected by the Galleri test. Continue with all routine screening tests that your healthcare provider recommends. Missing routine screenings or ignoring symptoms can lead to a delayed diagnosis of cancer. PWNHealth also offers optional post-test counseling to discuss your result, which is included in your benefit.

This means that there is a suspicion of cancer, and additional tests are needed to see if you have cancer. The PWNHealth provider who ordered your test will share this result with you and what it may mean.

When you request the test, you are given the option to enter your primary healthcare provider’s contact information so your test result is automatically shared if a cancer signal is detected. If you do not have a primary healthcare provider, PWNHealth can help you find one in your area. The Galleri test can point to where in the body the cancer is coming from with high accuracy to help your primary healthcare provider guide next steps. Your primary healthcare provider should order appropriate follow-up testing to confirm if cancer is present.

This could mean that you have a cancer that is difficult to identify by the selected follow up diagnostic procedures, or that the result of the Galleri test is a false positive and that you do not have cancer. Testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. In the event that a diagnostic evaluation after a Galleri ​“Cancer Signal Detected” result does not confirm cancer, employees may be eligible for a complementary re-test with Galleri.

The request for a re-test must be placed by the healthcare provider managing the employee’s diagnostic evaluation. The re-test must be administered within 3 – 6 months after the initial Galleri test. To initiate a request for a re-test, the healthcare provider managing the employee’s diagnostic evaluation should contact GRAIL Medical Information at 833−694−2553 or medicalinformation@​grailbio.​com.

The Galleri test is a screening test that detects cancer signals in blood. When a signal is detected, the Galleri test also indicates where in the body the signal is coming from with high accuracy. The Galleri test is not a diagnostic test. Additional tests ordered by your primary healthcare provider are needed to confirm if cancer is present which may include blood work or imaging.

The Galleri test is looking for the presence of cancer at the time your blood is drawn, but you may develop cancer in the future. The test does not measure your risk of developing cancer in the future and it does not detect all cancers.

When you request the test, you are given the option to enter your primary healthcare provider’s contact information so your test result is automatically shared if a cancer signal is detected. If no cancer signal is detected, you can share the result with your provider, but we will not automatically send it.

Yes, when you request the test, you are given the option to enter your primary healthcare provider’s contact information so your test result is automatically shared if a cancer signal is detected. We will not automatically share a ​“No Cancer Signal Detected” result, but we encourage you to share it with your primary healthcare provider.

The provider that orders the test will receive your test result and share it with you. Your test result and medical information are confidential and access is limited to individuals who need the information for a specific purpose. 

For example:

  • If a cancer signal is detected, your test result will be shared with your primary healthcare provider (if you gave their contact information) so they can guide your next steps

WRITER only receives de-identified and aggregated information across all employees and will not receive individual results.

Get support

For questions about the Galleri test, please contact GRAIL Customer Service:

The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. Galleri is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of Galleri is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.

Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm cancer.

If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.

The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.

  1. Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021;32(9):1167-77. DOI:https://doi.org/10.1016/j.annonc.2021.05.806.

  2. The Galleri test does not detect all cancers nor does it measure your genetic risk of developing cancer in the future. It should be used in addition to routine screening tests your healthcare provider recommends.